SAGE Therapeutics
Sage Therapeutics is a biopharmaceutical company founded by Douglas Covey and Steven Paul in 2010 and headquartered in Cambridge, Massachusetts focused on the discovery and development of medicines to address central nervous system disorders.
3
Funding Rounds
$93.0m
Money raised
Overview
Sage Therapeutics is a biopharmaceutical company founded by Douglas Covey and Steven Paul in 2010 and headquartered in Cambridge, Massachusetts focused on the discovery and development of medicines to address central nervous system disorders.
| Name | Phone | Social networks | |
|---|---|---|---|
| Do***** Co*** | - | - | - |
| St**** Pa** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| St**** Pa** | - | - | |
| Ba*** E. Gr**** | - | - | |
| Je** Jo*** | - | - | linkedin twitter |
| Ge**** Go******** | - | - | - |
| Ge** Ge***** | - | - | - |
| Mi***** Co** | - | - | - |
| Li* Ba***** | - | - | - |
| Ja*** M. Fr**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Je** Jo*** | - | - | linkedin twitter |
Funding series
Funding Series Analysis
The company SAGE Therapeutics has raised a total of $20m in funding over 3 rounds.
Key Insights:
- SAGE Therapeutics Series B round: $20m
- SAGE Therapeutics Series C round March 2014: $38m
- SAGE Therapeutics Series A round, October 2011: $35m
SAGE Therapeutics Series B round
$20m
SAGE Therapeutics Series C round March 2014
$38m
SAGE Therapeutics Series A round, October 2011
$35m
Industries
SAGE Therapeutics is active in the following industries:
- Healthcare
- Therapeutics
- Biopharmaceutical
- Biomedical engineering
- Pharmaceutical industry
- Digital therapeutics
- Technology
- Biology
- Biotechnology
- Engineering
- Neuroscience